RZCMEDIUM SIGNALFINANCIAL10-K

RZC reported substantially higher net income while experiencing a significant decline in operating cash flow, creating a notable disconnect between earnings and cash generation.

The substantial improvement in net income paired with materially lower operating cash flow suggests potential timing differences or quality-of-earnings concerns that warrant investor scrutiny. The meaningful expansion in both assets and liabilities indicates significant business growth, but the cash flow decline raises questions about the sustainability of earnings performance.

Comparing 2026-02-20 vs 2025-02-21View on EDGAR →
FINANCIAL ANALYSIS

RZC's financial profile expanded meaningfully with total assets growing 32% to $156.6B and liabilities increasing proportionally, while net income grew substantially to $1.2B. However, operating cash flow declined materially from $9.4B to $4.1B, creating a concerning divergence between reported earnings and actual cash generation. The balance sheet remained stable with modest debt growth and healthy equity expansion, but the operating cash flow weakness overshadows the earnings improvement.

FINANCIAL STATEMENT CHANGES
Net Income
P&L
+64.9%
$717.0M$1.2B

Net income grew 64.9% — bottom-line growth signals improving overall business health.

Operating Cash Flow
Cash Flow
-56.3%
$9.4B$4.1B

Operating cash flow fell 56.3% — earnings quality concerns; investigate working capital changes and non-cash items.

Total Liabilities
Balance Sheet
+32.7%
$107.8B$143.0B

Liabilities grew 32.7% — significant increase in debt or obligations, assess impact on financial flexibility.

Total Assets
Balance Sheet
+31.9%
$118.7B$156.6B

Asset base grew 31.9% — expansion through organic growth, acquisitions, or capital deployment.

Capital Expenditure
Cash Flow
+31.6%
$19.0M$25.0M

Capital expenditure jumped 31.6% — major investment cycle underway; assess returns on deployment.

Cash & Equivalents
Balance Sheet
+25.3%
$3.3B$4.2B

Cash grew 25.3% — improving liquidity position supports investment and shareholder returns.

Stockholders Equity
Balance Sheet
+24.5%
$10.8B$13.5B

Equity base grew 24.5% — retained earnings accumulation or equity issuance strengthening the balance sheet.

Interest Expense
P&L
+20.4%
$304.0M$366.0M

Interest costs rose 20.4% — monitor debt levels and coverage ratio in rising rate environment.

Total Debt
Balance Sheet
+13.2%
$5.0B$5.7B

Debt rose 13.2% — additional borrowing for investment or operations; monitor coverage ratios.

LANGUAGE CHANGES
NEW — 2026-02-20
PRIOR — 2025-02-21
ADDED
As of January 30, 2026, 65,563,173 shares of the registrant s common stock were outstanding.
The consolidated financial statements herein include the assets, liabilities, and results of operations of RGA and its subsidiaries, all of which are wholly owned.
The terms Company , we , us and our in this Annual Report on Form 10-K refer to RGA and its subsidiaries.
The Company is a leading global provider of traditional life and health, and asset-intensive reinsurance, with operations in the U.S., Latin America, Canada, Europe, the Middle East, Africa, Asia and Australia.
Modified coinsurance and coinsurance with funds withheld agreements Unlike coinsurance arrangements, the assets supporting the reserves are retained by the ceding company.
+7 more — sign up free →
REMOVED
As of January 31, 2025, 66,024,444 shares of the registrant s common stock were outstanding.
The consolidated financial statements herein include the assets, liabilities, and results of operations of RGA and its subsidiaries, all of which are wholly owned, and is referred to as the Company , we , us and our in this Annual Report on Form 10-K.
The Company is a leading global provider of traditional life and health reinsurance and financial solutions with operations in the U.S., Latin America, Canada, Europe, the Middle East, Africa, Asia and Australia.
Modified coinsurance and coinsurance with funds withheld agreements Differ from coinsurance arrangements in that the assets supporting the reserves are retained by the ceding company.
This concern comes from both the absolute size of the risk and also through the volatility that changes in life expectancy can have on their reported earnings.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →